Makes you wonder why they didn’t just do that from the beginning.
Yep, it does. My guess is the mRNA type could be developed more quickly.
In hindsight, they probably should have developed a traditional vaccine in parallel. That way if the new type failed, there would be a fallback, albeit with possibly delayed delivery. And of course it would be acceptable to the large slice of the population that has turned out to be wary of the new type.
Because they invented the “vaccine” first, then the disease. This was a money/power ploy all along. Over a trillion dollars spent with not a lot to show for it except RICH Pharma Execs and shareholders.